FDA clears ProNova’s VIRTUE QA system for proton therapy quality assurance

The U.S. FDA has cleared ProNova Solutions’ VIRTUE QA device, a quality assurance system for charged-particle (proton) radiation therapy, via the 510(k) premarket notification pathway.

• The VIRTUE QA system is intended for quality assurance in charged-particle radiation therapy.
• The clearance was issued under product code LHN (charged-particle medical system) and falls under the FDA's Radiology committee.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.